We are live on ! Find out more
MA

Montag & Associates Portfolio holdings

AUM $2.15B
1-Year Est. Return 20.86%
This Fund
S&P 500
This Quarter Est. Return
+4.73%
1 Year Est. Return
+20.86%
3 Year Est. Return
+68%
5 Year Est. Return
+82.09%
10 Year Est. Return
+321.81%
AUM
$613M
AUM Growth
+$21.7M
Cap. Flow
-$3.21M
Cap. Flow %
-0.52%
Top 10 Hldgs %
22.48%
Holding
251
New
18
Increased
52
Reduced
87
Closed
9

Top Buys

Rank Stock Value
1
GILD icon
Gilead Sciences
GILD
+$4.1M
2
LLY icon
Eli Lilly
LLY
+$3.04M
3
INGR icon
Ingredion
INGR
+$2.73M
4
CSCO icon
Cisco
CSCO
+$2.62M
5
TDW icon
Tidewater
TDW
+$2.35M

Sector Composition

Rank Sector Weight
1 Healthcare 12.05%
2 Financials 10.79%
3 Industrials 9.01%
4 Consumer Staples 8.86%
5 Technology 7.68%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MDLZ icon
101
Mondelez International
MDLZ
$80.2B
$1.88M 0.31%
49,942
-290
-0.6% -$10.6K
SBUX icon
102
Starbucks
SBUX
$118B
$1.86M 0.3%
48,158
-2,700
-5% -$98.1K
MMM icon
103
3M
MMM
$94.1B
$1.85M 0.3%
15,491
-119
-0.8% -$14K
UPS icon
104
United Parcel Service
UPS
$89.7B
$1.85M 0.3%
17,985
+89
+0.5% +$8.94K
DIA icon
105
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
$46B
$1.84M 0.3%
10,985
-12,890
-54% -$2.14M
NEE icon
106
NextEra Energy
NEE
$186B
$1.78M 0.29%
69,580
-4,000
-5% -$97.3K
KMB icon
107
Kimberly-Clark
KMB
$37.5B
$1.69M 0.27%
15,799
+3
+0% +$319
PPH icon
108
VanEck Pharmaceutical ETF
PPH
$987M
$1.56M 0.25%
25,110
-25,260
-50% -$1.5M
POT
109
DELISTED
Potash Corp Of Saskatchewan
POT
$1.53M 0.25%
40,312
-50,180
-55% -$1.81M
COST icon
110
Costco
COST
$429B
$1.5M 0.25%
13,064
SSD icon
111
Simpson Manufacturing
SSD
$8.16B
$1.5M 0.25%
41,327
+15,200
+58% +$517K
LYV icon
112
Live Nation Entertainment
LYV
$42.1B
$1.5M 0.24%
+60,550
New +$1.36M
EV
113
DELISTED
Eaton Vance Corp.
EV
$1.48M 0.24%
39,125
CL icon
114
Colgate-Palmolive
CL
$74.2B
$1.46M 0.24%
21,366
-46
-0.2% -$3.08K
OMC icon
115
Omnicom Group
OMC
$24.6B
$1.42M 0.23%
20,000
-53,450
-73% -$3.72M
PM icon
116
Philip Morris
PM
$312B
$1.41M 0.23%
16,737
ES icon
117
Eversource Energy
ES
$28.4B
$1.4M 0.23%
29,664
-6,723
-18% -$308K
DWX icon
118
State Street SPDR S&P International Dividend ETF
DWX
$527M
$1.34M 0.22%
26,080
-800
-3% -$40.5K
RWT
119
Redwood Trust
RWT
$587M
$1.29M 0.21%
66,445
-2,388
-3% -$47.7K
ALL icon
120
Allstate
ALL
$70.1B
$1.27M 0.21%
21,640
THC icon
121
Tenet Healthcare
THC
$22.6B
$1.27M 0.21%
27,055
-24,120
-47% -$1.09M
ACN icon
122
Accenture
ACN
$101B
$1.26M 0.21%
15,621
-11,125
-42% -$893K
IOO icon
123
iShares Global 100 ETF
IOO
$8.72B
$1.19M 0.19%
30,320
-1,000
-3% -$39.6K
CERN
124
DELISTED
Cerner Corp
CERN
$1.19M 0.19%
+23,084
New +$1.21M
XLV icon
125
State Street Health Care Select Sector SPDR ETF
XLV
$43.2B
$1.18M 0.19%
19,382
+237
+1% +$13.9K

Similar funds

Montag & Associates's Q2 2014 Portfolio in Review

As of Q2 2014, Montag & Associates held 251 positions worth $613M, up 3.7% from $592M the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Montag & Associates's Q2 2014 filing shows 18 new, 52 increased, 87 reduced and 9 closed positions. Its largest new stake was Gilead Sciences: 52,627 shares worth $4.36M. The largest sale was CF Industries, an estimated $4.8M.

By sector, the portfolio is most concentrated in Healthcare at 12% of assets, up from 11% a quarter earlier, followed by Financials and Industrials.

  • Montag & Associates's largest Q2 2014 buy was Gilead Sciences: 52,627 shares worth $4.36M.
  • Montag & Associates added most to Eli Lilly in Q2 2014, an estimated $3.04M increase.
  • Montag & Associates's biggest Q2 2014 reduction was Huntington Ingalls Industries, cutting an estimated $3.97M.
  • Montag & Associates fully exited CF Industries in Q2 2014, selling an estimated $4.8M.
  • Montag & Associates's ten largest holdings make up 22% of its $613M portfolio in Q2 2014.
  • Montag & Associates opened 18 new positions and closed 9 in Q2 2014.
  • Montag & Associates's portfolio value rose 3.7% quarter-over-quarter to $613M.

Based on Montag & Associates's 13F filing for Q2 2014, filed 6 Aug 2014.